Skip to main content
BENLYSTA 120 mg/1.5mL injection, powder, lyophilized, for solution by GlaxoSmithKline LLC
BENLYSTA, 120 mg/1.5mL, injection, powder, lyophilized, for solution Drug class: B Lymphocyte Stimulator-specific Inhibitor. Available on prescription only. Listed by GlaxoSmithKline LLC.
Prescription only

BENLYSTA

belimumab

Listed by GlaxoSmithKline LLC

Strength
120 mg/1.5mL
Form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Class
B Lymphocyte Stimulator-specific Inhibitor

What it contains

  • Belimumab 120 mg/1.5mL

FDA record

Dosage form Injection, Powder, Lyophilized, For Solution
Route Intravenous
Drug class B Lymphocyte Stimulator-specific Inhibitor
Approval route BLA — biologic licence
NDC code 49401-101
FDA application BLA125370
RxNorm concept 1656395
Package sizes listed 1
Marketed since March 2011

Other products containing Belimumab

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

BENLYSTA

belimumab

Strength
200 mg/mL
Form
Solution
Class
B Lymphocyte Stimulator-specific Inhibi…
Rx only

GlaxoSmithKline LLC

Not stocked by us — reference only

BENLYSTA

belimumab

Strength
400 mg/5mL
Form
Injection, Powder, Lyophilized, For Solution
Class
B Lymphocyte Stimulator-specific Inhibi…
Rx only

GlaxoSmithKline LLC

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.